+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 3
Age: 18Years +
All Genders
ID06857773

Randomized Phase 3 Trial Comparing Combined Hepatic Arterial Infusion Pump and Systemic Therapy Versus Systemic Therapy Alone for Unresectable Colorectal Liver Metastases

Led by The Netherlands Cancer Institute · Updated on 2025-03-04

306

Participants Needed

1

Research Sites

260 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating a treatment approach for patients with colorectal cancer that has spread to the liver but cannot be surgically removed. This clinical trial compares the combined use of Hepatic Arterial Infusion Pump therapy and systemic chemotherapy against systemic chemotherapy alone to see if the combination improves survival. The study focuses on patients who have not received prior chemotherapy and do not have cancer outside the liver. Participants in the experimental group undergo surgery to implant a pump that delivers the chemotherapy drug Floxuridine directly to the liver, along with systemic chemotherapy given intravenously. The pump treatment cycles last four weeks, while systemic therapies such as FOLFOX or FOLFIRI are administered every two weeks. The control group receives standard systemic chemotherapy without the pump. Both groups have their tumor operability assessed by a specialized liver panel and complete quality of life questionnaires. Throughout the study, patients will have imaging scans including CT angiography and specialized scintigraphy to monitor treatment effects. Researchers will track overall survival for up to five years, along with secondary outcomes like progression-free survival, response rates, surgical complications, and quality of life. Safety and side effects of the therapies are carefully recorded. The total participation time may last several years with regular follow-up visits and evaluations.

CONDITIONS

Brief Title

Induction Treatment for Initially Unresectable Colorectal Liver Metastases: Combined Hepatic Arterial Infusion Pump Therapy With Systemic Therapy

Research Team

K

Koert FD Kuhlmann, MD PhD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here